26.11.2014 • News

Vencorex "Significantly Expanding" IPDI Capacity

Vencorex said it is "significantly expanding" its production capacity for isophorone diisocyanate (IPDI), the aliphatic isocyanate monomer used as feedstock for polyurethane resin, at its Pont de Claix, France, site.

CEO Magnus Lanner said the upgrade to 20,000 t/y by the end of 2016 will enhance Vencorex's capability to supply specialty areas while at the same time underlining the company's commitment to the isocyanates markets and further strengthening its position as one of the global leading suppliers.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.